THBS2
Basic information
Region (hg38): 6:169215780-169254050
Links
Phenotypes
GenCC
Source:
- Ehlers-Danlos syndrome, classic-like, 3 (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (140 variants)
- not_provided (20 variants)
- THBS2-related_disorder (16 variants)
- Ehlers-Danlos_syndrome,_classic-like,_3 (2 variants)
- Ehlers-Danlos_syndrome (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THBS2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003247.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | ||||
missense | 130 | 16 | 155 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 1 | 0 | 130 | 22 | 19 |
Highest pathogenic variant AF is 6.841143e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THBS2 | protein_coding | protein_coding | ENST00000366787 | 21 | 38265 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.556 | 0.444 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.21 | 587 | 759 | 0.774 | 0.0000501 | 7796 |
Missense in Polyphen | 214 | 351.14 | 0.60945 | 3565 | ||
Synonymous | -0.248 | 334 | 328 | 1.02 | 0.0000263 | 2159 |
Loss of Function | 5.58 | 13 | 59.5 | 0.219 | 0.00000283 | 625 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.000304 | 0.000298 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000977 | 0.0000967 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Ligand for CD36 mediating antiangiogenic properties. {ECO:0000269|PubMed:20714802}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Phagosome - Homo sapiens (human);Malaria - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);miRNA targets in ECM and membrane receptors;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;miR-509-3p alteration of YAP1-ECM axis;PI3K-Akt Signaling Pathway;Signal Transduction;Post-translational protein modification;Metabolism of proteins;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;O-glycosylation of TSR domain-containing proteins;Beta1 integrin cell surface interactions;O-linked glycosylation;Alpha4 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.521
Intolerance Scores
- loftool
- 0.108
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.05
Haploinsufficiency Scores
- pHI
- 0.745
- hipred
- Y
- hipred_score
- 0.603
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.883
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Thbs2
- Phenotype
- limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cell adhesion;negative regulation of angiogenesis;positive regulation of synapse assembly
- Cellular component
- extracellular region;basement membrane;platelet alpha granule;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;calcium ion binding;protein binding;heparin binding